The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution

PURPOSE: To explore whether changes in tumor size impact survival in advanced non-small-cell lung cancer (NSCLC) after target therapy, especially in patients with evaluation of stable disease (SD), and to review the applicability of the Response Evaluation Criteria in Solid Tumors (RECIST) criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jianwei, Huang, Yan, Li, Xiaoling, Guo, Ying, Zhao, Yuanyuan, Xue, Cong, Hu, Zhihuang, Zhang, Li, Zhao, Hongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501954/
https://www.ncbi.nlm.nih.gov/pubmed/23172990
http://dx.doi.org/10.2147/OTT.S38441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501954/
https://www.ncbi.nlm.nih.gov/pubmed/23172990
http://dx.doi.org/10.2147/OTT.S38441

Ejemplares similares